vidarabine phosphate has been researched along with Carcinoma, Epidermoid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Christiansen, H; Hermann, RM; Lucke, EM; Nitsche, M; Peters, K; Pradier, O; Rave-Frank, M; Schmidberger, H | 1 |
| Frankenberg, D; Hess, CF; Laurent, D; Pradier, O; Rave-Fränk, M; Schmidberger, H | 1 |
| Metch, B; Saiers, JH; Taylor, SA; Von Hoff, DD; Weiss, GB | 1 |
3 other study(ies) available for vidarabine phosphate and Carcinoma, Epidermoid
| Article | Year |
|---|---|
The combined effect of fludarabine monophosphate and radiation as well as gemcitabine and radiation on squamous carcinoma tumor cell lines in vitro.
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Deoxycytidine; Gemcitabine; Humans; Radiation-Sensitizing Agents; Vidarabine Phosphate | 2008 |
Radiation rendered more cytotoxic by fludarabine monophosphate in a human oropharynx carcinoma cell-line than in fetal lung fibroblasts.
Topics: Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Fetus; Fibroblasts; Humans; Lung; Oropharyngeal Neoplasms; Radiation-Sensitizing Agents; Tumor Cells, Cultured; Vidarabine Phosphate | 1998 |
Phase II trial of fludarabine phosphate in patients with head and neck cancer: a Southwest Oncology Group Study.
Topics: Arabinonucleotides; Carcinoma, Squamous Cell; Drug Evaluation; Head and Neck Neoplasms; Hematopoiesis; Humans; Vidarabine Phosphate | 1987 |